Paclitaxel inhibits proliferation of cell lines responsible for metal stent obstruction: Possible topical application in malignant bile duct obstructions

Investigative Radiology

Volumn 37, Issue 7, 2002, Pages 399-404

  Kalinowski, Marc ^a   Alfke, Heiko ^a   Kleb, Beate ^a   Dürfeld, Frank ^a   Wagner, Hans Joachim ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Biliary malignancies; Cell culture; Experimental studies; Paclitaxel

Indexed keywords

PACLITAXEL;

ARTICLE; BILE DUCT CANCER; BILE DUCT OBSTRUCTION; CELL CULTURE; CELL LINE; CELL PROLIFERATION; CELL VACUOLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG COATING; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; FIBROBLAST; HUMAN; HUMAN CELL; INCUBATION TIME; PHOTOMETRY; PRIORITY JOURNAL; STENT;

EID: 0036088453     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-200207000-00007     Document Type: Article

References (31)

1. Carcinoma of the extrahepatic bile ducts: Histologic types, stage of disease, grade and survival rates
2. Eastern Cooperative Oncology Group experience with chemotherapy for inoperative gallbladder and bile duct cancer
3. Metalic stents in malignant biliary obstruction
4. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction
5. Complications of percutaneously inserted biliary Wall stents
6. Localized paclitaxel delivery
7. Antiproliferative stent coatings: Taxol and related compounds
8. Coated stents: Local pharmacology
9. Paclitaxel (Taxol)
10. Lipopolysaccharide antagonists block Taxol induced signaling in murine macrophages
11. The taxoids: Paclitaxel and docetaxel
12. Promotion of microtubule assembly in vitro by Taxol
13. cdc2 coincident with Taxol-induced apoptosis
14. Taxol-treated fibroblasts acquire an epithelioid shape and a circular pattern of actin bundles
15. In vitro antitumor activity of mitomycin C derivative (RM 49) and a new anticancer antibiotic (FK 973) against lung cancer cell lines determined by tetrazolium dye (MTT assay)
16. Role of the microtubular system in morphological organization of normal and oncogene-transfected epithelial cells
17. Taxol stabilizes microtubules in mouse fibroblast cells
18. Mechanism of mitotic block and inhibition of cell proliferation by Taxol at low concentrations
19. Pharmaceutical aspects of paclitaxel
20. Difference in cytotoxicity of paclitaxel against neoplastic and normal cells
21. Adenocarcinoma of the stomach, pancreas, liver and biliary tracts: Survival of 328 patients treated with fluoropyrimidine therapy
22. Adriamycin, BCNU, ftorafur chemotherapy of pancreatic and biliary tract cancer
23. Phase II study of paclitaxel therapy for unresectable biliary tree carcinomas
24. Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationship in humans
25. Phase I trial of intraperitoneal Taxol: A gynecologic oncology group study
26. Clinical pharmacokinetics of paclitaxel
27. In vitro evaluation of antibiotic prophylaxis in the prevention of biliary stent blockage
28. New biliary endoprosthesis less liable to block in biliary infections: Description and in vitro studies
29. Protein adsorption and bacterial adhesion to biliary stent materials
30. Biological characteristics of primary cultures of human gallbladder epithelial cells
31. Establishment and immunological characterization of cultured human gallbladder epithelial cells